Literature DB >> 7606820

Genomic instability due to germline p53 mutations drives preneoplastic progression toward cancer in human cells.

M A Tainsky1, F Z Bischoff, L C Strong.   

Abstract

Cells heterozygous for mutations in p53 demonstrate extreme genomic instability and develop mutations detectable at the chromosome level as well as the molecular level. This genomic instability causes initially nontumorigenic ras-expressing immortal LFS cells to progress to a tumorigenic state presumably due to additional mutational events. It is not surprising that LFS families with these p53 mutations develop the additional mutations necessary for cancer to occur at such high frequencies. This observation is consistent with increased cancer rates in these families being due to abrogation of a rate limiting step rather than a rate expected for one less step in a multistep carcinogenic process. Although p53 has been shown to be able to function as a transcription factor, mutations in p53 appear to affect genomic stability in LFS fibroblasts with double minutes and telomeric associations being prominent early events. One possibility is that p53 controls the expression of genes required for fidelity of replication or telomerase activity. Alternatively p53 may itself be a replication factor like the transcription factor CTF. In the future, we plan to investigate whether p53 plays a direct role in replication.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7606820     DOI: 10.1007/BF00690210

Source DB:  PubMed          Journal:  Cancer Metastasis Rev        ISSN: 0167-7659            Impact factor:   9.264


  13 in total

1.  Altered cell cycle arrest and gene amplification potential accompany loss of wild-type p53.

Authors:  L R Livingstone; A White; J Sprouse; E Livanos; T Jacks; T D Tlsty
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

Review 2.  Why are transformed cells immortal? Is the process reversible?

Authors:  J R Smith; Y Ning; O M Pereira-Smith
Journal:  Am J Clin Nutr       Date:  1992-06       Impact factor: 7.045

3.  Segregation analysis of cancer in families of childhood soft-tissue-sarcoma patients.

Authors:  E D Lustbader; W R Williams; M L Bondy; S Strom; L C Strong
Journal:  Am J Hum Genet       Date:  1992-08       Impact factor: 11.025

4.  Susceptibility to ras oncogene transformation is coregulated with signal transduction through growth factor receptors.

Authors:  P J Chiao; P Kannan; S O Yim; D B Krizman; T A Wu; G E Gallick; M A Tainsky
Journal:  Oncogene       Date:  1991-05       Impact factor: 9.867

5.  Susceptibility for N-ras-mediated transformation requires loss of tumor suppressor activity.

Authors:  D B Krizman; B C Giovanella; M A Tainsky
Journal:  Somat Cell Mol Genet       Date:  1990-01

6.  Normal cytotoxic response of skin fibroblasts from patients with Li-Fraumeni familial cancer syndrome to DNA-damaging agents in vitro.

Authors:  J B Little; J Nove; W K Dahlberg; P Troilo; W W Nichols; L C Strong
Journal:  Cancer Res       Date:  1987-08-01       Impact factor: 12.701

7.  Spontaneous abnormalities in normal fibroblasts from patients with Li-Fraumeni cancer syndrome: aneuploidy and immortalization.

Authors:  F Z Bischoff; S O Yim; S Pathak; G Grant; M J Siciliano; B C Giovanella; L C Strong; M A Tainsky
Journal:  Cancer Res       Date:  1990-12-15       Impact factor: 12.701

8.  Wild-type p53 restores cell cycle control and inhibits gene amplification in cells with mutant p53 alleles.

Authors:  Y Yin; M A Tainsky; F Z Bischoff; L C Strong; G M Wahl
Journal:  Cell       Date:  1992-09-18       Impact factor: 41.582

9.  Spontaneous in vitro immortalization of breast epithelial cells from a patient with Li-Fraumeni syndrome.

Authors:  J W Shay; G Tomlinson; M A Piatyszek; L S Gollahon
Journal:  Mol Cell Biol       Date:  1995-01       Impact factor: 4.272

10.  Germ line p53 mutations in a familial syndrome of breast cancer, sarcomas, and other neoplasms.

Authors:  D Malkin; F P Li; L C Strong; J F Fraumeni; C E Nelson; D H Kim; J Kassel; M A Gryka; F Z Bischoff; M A Tainsky
Journal:  Science       Date:  1990-11-30       Impact factor: 47.728

View more
  12 in total

1.  Proapoptotic p53-interacting protein 53BP2 is induced by UV irradiation but suppressed by p53.

Authors:  C D Lopez; Y Ao; L H Rohde; T D Perez; D J O'Connor; X Lu; J M Ford; L Naumovski
Journal:  Mol Cell Biol       Date:  2000-11       Impact factor: 4.272

Review 2.  The two faces of tumor suppressor p53.

Authors:  M L Smith; A J Fornace
Journal:  Am J Pathol       Date:  1996-04       Impact factor: 4.307

3.  Inhibition of stress-inducible kinase pathways by tumorigenic mutant p53.

Authors:  Yoichi Ohiro; Anny Usheva; Shinichiro Kobayashi; Shannon L Duffy; Regan Nantz; David Gius; Nobuo Horikoshi
Journal:  Mol Cell Biol       Date:  2003-01       Impact factor: 4.272

Review 4.  Chromosome instability and deregulated proliferation: an unavoidable duo.

Authors:  Courtney H Coschi; Frederick A Dick
Journal:  Cell Mol Life Sci       Date:  2012-01-06       Impact factor: 9.261

5.  Genomic alterations associated with loss of heterozygosity for TP53 in Li-Fraumeni syndrome fibroblasts.

Authors:  E C Burt; L A James; M J Greaves; J M Birch; J M Boyle; J M Varley
Journal:  Br J Cancer       Date:  2000-08       Impact factor: 7.640

6.  Radiation-induced G1 arrest is not defective in fibroblasts from Li-Fraumeni families without TP53 mutations.

Authors:  J M Boyle; M J Greaves; R S Camplejohn; J M Birch; S A Roberts; J M Varley
Journal:  Br J Cancer       Date:  1999-04       Impact factor: 7.640

7.  siRNA screening identifies differences in the Fanconi anemia pathway in BALB/c-Trp53+/- with susceptibility versus C57BL/6-Trp53+/- mice with resistance to mammary tumors.

Authors:  M Böhringer; K Obermeier; N Griner; D Waldraff; E Dickinson; K Eirich; D Schindler; M Hagen; D J Jerry; L Wiesmüller
Journal:  Oncogene       Date:  2013-02-25       Impact factor: 9.867

8.  PIGN gene expression aberration is associated with genomic instability and leukemic progression in acute myeloid leukemia with myelodysplastic features.

Authors:  Emmanuel K Teye; Abigail Sido; Ping Xin; Niklas K Finnberg; Prashanth Gokare; Yuka I Kawasawa; Anna C Salzberg; Sara Shimko; Michael Bayerl; W Christopher Ehmann; David F Claxton; Witold B Rybka; Joseph J Drabick; Hong-Gang Wang; Thomas Abraham; Wafik S El-Deiry; Robert A Brodsky; Raymond J Hohl; Jeffrey J Pu
Journal:  Oncotarget       Date:  2017-05-02

9.  Characterization of tumors with ultralow tumor mutational burden in Japanese cancer patients.

Authors:  Keiichi Hatakeyama; Takeshi Nagashima; Keiichi Ohshima; Sumiko Ohnami; Shumpei Ohnami; Yuji Shimoda; Akane Naruoka; Koji Maruyama; Akira Iizuka; Tadashi Ashizawa; Tohru Mochizuki; Kenichi Urakami; Yasuto Akiyama; Ken Yamaguchi
Journal:  Cancer Sci       Date:  2020-08-07       Impact factor: 6.716

10.  Chromosome instability is a predominant trait of fibroblasts from Li-Fraumeni families.

Authors:  J M Boyle; E L Mitchell; M J Greaves; S A Roberts; K Tricker; E Burt; J M Varley; J M Birch; D Scott
Journal:  Br J Cancer       Date:  1998-06       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.